ATE312349T1 - Differentielle diagnose von neurodegeneration - Google Patents
Differentielle diagnose von neurodegenerationInfo
- Publication number
- ATE312349T1 ATE312349T1 AT99934543T AT99934543T ATE312349T1 AT E312349 T1 ATE312349 T1 AT E312349T1 AT 99934543 T AT99934543 T AT 99934543T AT 99934543 T AT99934543 T AT 99934543T AT E312349 T1 ATE312349 T1 AT E312349T1
- Authority
- AT
- Austria
- Prior art keywords
- neurodegeneration
- differential diagnosis
- methods
- quantification
- relates
- Prior art date
Links
- 230000004770 neurodegeneration Effects 0.000 title abstract 4
- 238000003748 differential diagnosis Methods 0.000 title abstract 3
- 238000000034 method Methods 0.000 abstract 3
- 238000003556 assay Methods 0.000 abstract 2
- 230000000926 neurological effect Effects 0.000 abstract 2
- 238000011002 quantification Methods 0.000 abstract 2
- 238000011895 specific detection Methods 0.000 abstract 2
- 101150004420 RAB3A gene Proteins 0.000 abstract 1
- 108010057722 Synaptosomal-Associated Protein 25 Proteins 0.000 abstract 1
- 102000004183 Synaptosomal-Associated Protein 25 Human genes 0.000 abstract 1
- 102000003802 alpha-Synuclein Human genes 0.000 abstract 1
- 108090000185 alpha-Synuclein Proteins 0.000 abstract 1
- 210000001124 body fluid Anatomy 0.000 abstract 1
- 239000010839 body fluid Substances 0.000 abstract 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 abstract 1
- 239000013068 control sample Substances 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2835—Movement disorders, e.g. Parkinson, Huntington, Tourette
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
- Eye Examination Apparatus (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98870148 | 1998-07-03 | ||
| EP98870236 | 1998-11-03 | ||
| EP99870069 | 1999-04-09 | ||
| PCT/EP1999/004483 WO2000002053A2 (en) | 1998-07-03 | 1999-06-29 | Differential diagnosis of neurodegeneration |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE312349T1 true ATE312349T1 (de) | 2005-12-15 |
Family
ID=27239769
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99934543T ATE312349T1 (de) | 1998-07-03 | 1999-06-29 | Differentielle diagnose von neurodegeneration |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP1095278B1 (de) |
| JP (3) | JP2002519702A (de) |
| CN (1) | CN1316055A (de) |
| AT (1) | ATE312349T1 (de) |
| AU (1) | AU754062B2 (de) |
| BR (1) | BR9911291A (de) |
| CA (1) | CA2329523A1 (de) |
| DE (1) | DE69928809T2 (de) |
| DK (1) | DK1095278T3 (de) |
| ES (1) | ES2255280T3 (de) |
| WO (1) | WO2000002053A2 (de) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10041478A1 (de) | 2000-08-24 | 2002-03-14 | Sanol Arznei Schwarz Gmbh | Neue pharmazeutische Zusammensetzung |
| WO2002075317A2 (en) * | 2001-03-15 | 2002-09-26 | Novartis Ag | Screening for drugs against disorders associated with schizophrenia |
| WO2003044051A1 (en) * | 2001-11-20 | 2003-05-30 | Atgen Co., Ltd. | Novel peptides conferring environmental stress resistance and fusion proteins including said peptides |
| GB0203446D0 (en) * | 2002-02-14 | 2002-04-03 | Univ Lancaster | Detection and/or monitoring of synuclein-related diseases |
| US9034337B2 (en) | 2003-10-31 | 2015-05-19 | Prothena Biosciences Limited | Treatment and delay of outset of synucleinopathic and amyloidogenic disease |
| WO2005001483A2 (en) * | 2003-06-27 | 2005-01-06 | Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts | Methods for diagnisis and differential diagnosis of dementia disorders |
| WO2005047860A2 (en) | 2003-11-08 | 2005-05-26 | Elan Pharmaceuticals, Inc. | Antibodies to alpha-synuclein |
| PT2211183E (pt) * | 2003-11-19 | 2013-05-31 | Satoris Inc | Método para diagnosticar e monitorizar a doença de alzheimer |
| US20060094064A1 (en) * | 2003-11-19 | 2006-05-04 | Sandip Ray | Methods and compositions for diagnosis, stratification, and monitoring of alzheimer's disease and other neurological disorders in body fluids |
| DE10361258A1 (de) | 2003-12-24 | 2005-07-28 | Schwarz Pharma Ag | Verwendung von substituierten 2-Aminotetralinen zur vorbeugenden Behandlung von Morbus Parkinson |
| AT500321B1 (de) * | 2003-12-30 | 2006-02-15 | Red Bull Gmbh | Verfahren zur diagnose des down-syndroms |
| DE102004014841B4 (de) | 2004-03-24 | 2006-07-06 | Schwarz Pharma Ag | Verwendung von Rotigotin zur Behandlung und Prävention des Parkinson-Plus-Syndroms |
| AU2005323173A1 (en) * | 2004-12-01 | 2006-07-13 | The Curators Of The University Of Missouri | Modulator of alpha-synuclein toxicity |
| ES2441253T3 (es) * | 2006-11-17 | 2014-02-03 | Friedrich-Alexander-Universität Erlangen-Nürnberg | Procedimiento para diagnosticar diferencialmente demencias |
| PL2118300T3 (pl) * | 2007-02-23 | 2015-11-30 | Prothena Biosciences Ltd | Zapobieganie i leczenie synukleinopatii i amyloidozy |
| EP2020602A1 (de) * | 2007-08-02 | 2009-02-04 | Araclon Biotech | Hochempfindliche Immuntests und Kits zur Bestimmung biologisch interessanter Peptide und Proteine |
| JP2009052933A (ja) * | 2007-08-24 | 2009-03-12 | Rakuno Gakuen | プリオン病の検出方法及び診断キット |
| WO2009039586A2 (en) * | 2007-09-28 | 2009-04-02 | Powmri Limited | Biomarkers for parkinson's disease |
| WO2009086306A1 (en) | 2007-12-21 | 2009-07-09 | Whitehead Institute For Biomedical Research | Modulators of alpha-synuclein toxicity |
| DK2282758T3 (en) * | 2008-04-29 | 2019-02-25 | Bioarctic Ab | ANTIBODIES AND VACCINES FOR USE IN THERAPEUTIC AND DIAGNOSTIC PROCEDURES FOR ALPHA-SYNUCLEIN-RELATED DISORDERS |
| US20110159527A1 (en) * | 2008-06-16 | 2011-06-30 | Michael Gebhard Schlossmacher | Methods and kits for diagnosing neurodegenerative disease |
| US20120190652A1 (en) * | 2009-09-16 | 2012-07-26 | United Arab Emirates University | Diagnostic agent for parkinson's disease |
| CA2784919A1 (en) | 2010-01-26 | 2011-07-26 | Banyan Biomarkers, Inc. | Compositions and methods relating to argininosuccinate synthetase |
| EP2539366B1 (de) | 2010-02-26 | 2017-11-08 | BioArtic Neuroscience AB | Protofibril-bindende antikörper und deren verwendung in therapeutischen und diagnostischjen verfahren für parkinson-krankheit, lewy-körperchen demenz oder anderen alpha-synucleinopathien |
| CN102918397A (zh) * | 2010-04-01 | 2013-02-06 | 班扬生物标记公司 | 用于神经毒性检测的标志物和测定方法 |
| GB201011420D0 (en) * | 2010-07-06 | 2010-08-18 | United Arab Emirates Universit | Method for diagnosis |
| RU2441240C1 (ru) * | 2010-10-05 | 2012-01-27 | Государственное образовательное учреждение высшего профессионального образования "Московский государственный медико-стоматологический университет" Министерства здравоохранения и социального развития Российской Федерации | Способ диагностики аксонально-демиелинизирующих полиневропатий |
| UA118441C2 (uk) * | 2012-10-08 | 2019-01-25 | Протена Біосаєнсиз Лімітед | Антитіло, що розпізнає альфа-синуклеїн |
| WO2015111430A1 (ja) | 2014-01-21 | 2015-07-30 | 株式会社 島津製作所 | Ａｐｐ切断型ペプチドの測定方法 |
| EP4040157A1 (de) | 2014-05-22 | 2022-08-10 | Shimadzu Corporation | Surrogatbiomarker zur beurteilung der intrazerebralen amyloid-beta-peptid-akkumulation und verfahren zur analyse davon |
| BR112017004883A2 (pt) * | 2014-09-10 | 2017-12-05 | Abbvie Deutschland | ensaio de diagnóstico baseado em fragmento de rgma |
| EP4424704A3 (de) | 2015-09-16 | 2024-12-25 | Shimadzu Corporation | Multiplex-biomarker zur verwendung bei der beurteilung des akkumulationszustands von amyloid b im gehirn und analyseverfahren für besagte beurteilung |
| EP3242134A1 (de) * | 2016-05-04 | 2017-11-08 | Euroimmun Medizinische Labordiagnostika AG | Assay zur diagnose einer neurologischen krankheit |
| US11852635B2 (en) * | 2016-11-16 | 2023-12-26 | Nano Somix, Inc | Quantification of subpopulations of exosomes and diagnosis of neurogenerative disorders |
| US10364286B2 (en) * | 2016-12-22 | 2019-07-30 | H. Lundbeck A/S | Monoclonal anti-alpha-synuclein antibodies for preventing tau aggregation |
| GB201814807D0 (en) * | 2018-09-12 | 2018-10-24 | Univ Newcastle | Dementia Biomarkers |
| EP3660509B1 (de) * | 2018-11-29 | 2022-03-09 | Hugel Inc. | Zellbasiertes verfahren zur bestimmung der aktivität von botulinumtoxin |
| GB202005732D0 (en) * | 2020-04-20 | 2020-06-03 | Synpromics Ltd | Regulatory nucleic acid sequences |
| HUE072262T2 (hu) | 2020-06-26 | 2025-11-28 | Bioarctic Ab | Alfa-szinuklein protofibrillum-kötõ antitestek |
| WO2022115705A2 (en) * | 2020-11-30 | 2022-06-02 | Enigma Biointelligence, Inc. | Non-invasive assessment of alzheimer's disease |
-
1999
- 1999-06-29 AT AT99934543T patent/ATE312349T1/de active
- 1999-06-29 EP EP99934543A patent/EP1095278B1/de not_active Expired - Lifetime
- 1999-06-29 BR BR9911291-4A patent/BR9911291A/pt not_active IP Right Cessation
- 1999-06-29 DK DK99934543T patent/DK1095278T3/da active
- 1999-06-29 CN CN99810286.5A patent/CN1316055A/zh active Pending
- 1999-06-29 JP JP2000558397A patent/JP2002519702A/ja active Pending
- 1999-06-29 AU AU50290/99A patent/AU754062B2/en not_active Ceased
- 1999-06-29 ES ES99934543T patent/ES2255280T3/es not_active Expired - Lifetime
- 1999-06-29 DE DE69928809T patent/DE69928809T2/de not_active Expired - Lifetime
- 1999-06-29 WO PCT/EP1999/004483 patent/WO2000002053A2/en not_active Ceased
- 1999-06-29 CA CA002329523A patent/CA2329523A1/en not_active Abandoned
-
2005
- 2005-11-10 JP JP2005326503A patent/JP2006091025A/ja active Pending
-
2009
- 2009-10-28 JP JP2009247559A patent/JP4580455B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1095278B1 (de) | 2005-12-07 |
| DE69928809D1 (de) | 2006-01-12 |
| AU5029099A (en) | 2000-01-24 |
| JP4580455B2 (ja) | 2010-11-10 |
| JP2002519702A (ja) | 2002-07-02 |
| EP1095278A2 (de) | 2001-05-02 |
| BR9911291A (pt) | 2001-12-04 |
| CA2329523A1 (en) | 2000-01-13 |
| DE69928809T2 (de) | 2006-08-31 |
| JP2010019864A (ja) | 2010-01-28 |
| WO2000002053A3 (en) | 2000-02-24 |
| ES2255280T3 (es) | 2006-06-16 |
| WO2000002053A2 (en) | 2000-01-13 |
| CN1316055A (zh) | 2001-10-03 |
| JP2006091025A (ja) | 2006-04-06 |
| AU754062B2 (en) | 2002-10-31 |
| DK1095278T3 (da) | 2006-04-18 |
| HK1036834A1 (en) | 2002-01-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69928809D1 (de) | Differentielle diagnose von neurodegeneration | |
| WO2002057787A3 (en) | Detection of survivin in the biological fluids of cancer patients | |
| ATE406834T1 (de) | System zur überwachung der konzentration von analyten in körperflüssigkeiten | |
| DE60233949D1 (de) | Diagnostische marker für schlaganfall und hirntrauma sowie verfahren zur verwendung davon | |
| CA2263063A1 (en) | Method for diagnosing and distinguishing stroke and diagnostic devices for use therein | |
| CY1109062T1 (el) | Μεθοδοι ανιχνευσεως και αναστολης της αγγειογενεσεως | |
| DK1381866T3 (da) | Fremgangsmåde til differentialdiagnosticering af Alzheimers demens samt anordning hertil | |
| EP1731619A3 (de) | Krebsmarker | |
| WO2004112570A3 (en) | Detection of survivin in the biological fluids of cancer patients | |
| GB9506050D0 (en) | Assaying collagen fragments in body fluids | |
| DE50104561D1 (de) | Verfahren zur Diagnose von Sepsis unter Bestimmung löslicher Cytokeratinfragmente | |
| DE60129855D1 (de) | Differenzielles immunoassay für myoglobin | |
| WO2000026668A3 (en) | S100 proteins and autoantibodies as serum markers for cancer | |
| KR960705211A (ko) | 체액내 bpi의 정량 방법(method for quantifying bpi in body fluids) | |
| DE50103032D1 (de) | Verfahren zur Diagnose von Sepsis unter Bestimmung von CA 19-9 | |
| ATE377192T1 (de) | Diagnostisches verfahren für eierstock- und endometriumtumore basierend auf dem nachweis des l1-adhäsionsmoleküls | |
| DK0720745T3 (da) | Fremgangsmåde til kvantificering af ekstracellulært BPI i legemsvæsker | |
| WO2002057793A3 (en) | Method of detecting prp protein and kits therefor | |
| DK0958500T3 (da) | Immunohistokemisk påvisningsassay for carcinomproliferationsstatus | |
| BR9913770A (pt) | Processo de ensaio para determinação da cobalamina ligada a transcobalamina ii (tcii) em uma amostra de corpo, kit para uso em um ensaio diagnóstico, e, uso de holo-tc ii | |
| BR0115689A (pt) | Análise de expressão de inibidor de diferenciação de ácidos nucléicos e polipeptìdeos úteis na diagnose e tratamento de câncer da próstata | |
| DK1664330T3 (da) | Blod- og urintest | |
| PT1297342E (pt) | Metodo de diagnostico para a doenca de alzheimer com base em holo-transcobalamina ii | |
| ATE322687T1 (de) | Nachweis von prostatakrebs durch bestimmen des verhältnisses von psa zu igf-1 | |
| WO2001096599A3 (en) | Methods for quantitative determination of b-fibronectin in biological fluids and tissues |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1095278 Country of ref document: EP |